Thank you very much. That's an excellent question and provides me with the opportunity to talk a little bit about TB, which in some ways is the most neglected of the three diseases. I think there is much more public discussion on AIDS and on malaria.
TB Reach has been extremely important not just for the Global Fund, but for the international efforts to overcome tuberculosis. Let me tell you why. For tuberculosis, in principle, we have a curative treatment, which is fantastic. That's what we don't have for AIDS, but we have it for tuberculosis. There are challenges because there is increasing resistence to some of these standard treatments, but we know we have the drugs and we have the treatment. If it's followed it's a cure. The biggest problem with TB is to find who has active tuberculosis; the active case finding. That's the most important challenge. If we want to overcome tuberculosis it's that challenge. In vulnerable communities people often do not come forward to present themselves so they can be diagnosed and then treated. That's exactly what TB Reach does. It helps enormously with the identification of the patients so that they can then be followed up and treated.
Our great partners at the Stop TB Partnership call the biggest challenge the “missed” three million. We know every year there are three million people suffering from active tuberculosis who are not diagnosed. It's not that we could not pay for the treatment. They are simply not diagnosed. They are living somewhere in remote areas, in slum areas and in the big cities—Asia is a driver for this kind of tuberculosis—and TB Reach and the Stop TB Partnership are our key allies in addressing that particular aspect. We would be very grateful if the support for TB Reach could continue. It's very complementary. We pay for the diagnosis and treatment, and they help to reach the people. So full support for that and thank you for that important question.